By Marcus Moore, CPA, Manager at Blue & Co. Nonprofit boards are responsible for protecting mission, strategy, and long-term sustainability. Yet in many boardrooms, the most important question is rarely […]
Read More
By Caleb Young, CPA, Manager at Blue & Co. The Advantage of Cost Segregation Studies For Real Estate Investment What if you could significantly increase your cash flow in the first year of […]
Read More
After nearly two months of uncertainty and legal challenges to the initial 340B rebate model pilot program, HRSA is now seeking public input on a future pilot program through March […]
Read More
Congress has again postponed the next PAMA clinical lab reporting period. Hospitals and outreach labs should still prepare. The new guidelines moved the reporting window to May 1, 2026, through […]
Read More
A significant policy shift is about to reshape how hospitals structure, track, and bill for their off-campus Provider-Based Hospital Outpatient Departments (PB HOPDs). With the approval of Section 6225 of […]
Read More
By Jonah Gjertson, Senior Consultant at Blue & Co. One full year into a new trade philosophy within the United States, automotive manufacturing in North America experienced a net contraction […]
Read More
CARMEL, Ind. (February 1, 2026) – Blue & Co., LLC, a Top-60 accounting and advisory firm based in Carmel, IN, is expanding into Texas. Effective February 1, 2026, D & […]
Read More
A new recertification window is now open for the 2026 grantee recertification period for Consolidated Health Centers, Federally Qualified Health Centers & Look-Alikes, Ryan White Clinics, Comprehensive Hemophilia Treatment Centers, […]
Read More
The One Big Beautiful Bill Act (OBBBA) introduces a series of downstream financial impacts that hospitals should closely monitor, particularly as they relate to Medicaid coverage shifts and the resulting […]
Read More
By Angela Crawford, CPA, Director at Blue & Co. Indiana Form NP-20R, Not-For-Profit Organization’s Report Indiana not-for-profits are required to file Form NP-20R every five years. The due dates for […]
Read More
For hospitals that would like to withdraw an approved Geographic Reclassification, the publishing of the FY 2027 proposed rule starts the 45-day window for withdrawing approved Medicare Geographic Classification Review […]
The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients. However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]
By Joell Grisel, CPA, Director at Blue & Co. Financial technology keeps evolving at a pace that is hard for many not-for-profits to keep up with. At Blue & Co., […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
